Cary Street Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5K Sell
140
-7
-5% -$1.5K ﹤0.01% 1058
2026
Q1
$32.5K Buy
147
+7
+5% +$1.71K ﹤0.01% 955
2025
Q4
$35.5K Sell
140
-142
-50% -$35.7K ﹤0.01% 950
2025
Q3
$69.8K Buy
282
+30
+12% +$7.18K ﹤0.01% 878
2025
Q2
$60.5K Buy
252
+5
+2% +$1.16K ﹤0.01% 860
2025
Q1
$56K Sell
247
-143
-37% -$31.5K ﹤0.01% 823
2024
Q4
$80.2K Buy
+390
New +$85.6K ﹤0.01% 789

Other funds holding STE

Cary Street Partners's STE Position: Q2 2026 in Review

Cary Street Partners reduced its Steris (STE) stake by 4.8% in Q2 2026, selling an estimated $1.5K and leaving 140 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1058.

Cary Street Partners first reported a position in STE in Q4 2024 and has held it in 7 quarters since. The position peaked at $80.2K in Q4 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Cary Street Partners held 140 shares of Steris worth $29.5K as of Q2 2026.
  • Cary Street Partners sold 7 Steris shares in Q2 2026, an estimated $1.5K.
  • Steris made up ﹤0.01% of Cary Street Partners's portfolio in Q2 2026, its #1058 holding.
  • Cary Street Partners first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Steris position peaked at $80.2K in Q4 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.